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Purpose  
G protein coupled receptor kinases (GRKs), in addition to playing important roles in controlling the 
activity of drug receptors, may also modulate the activity of non-receptor proteins involved in cancer 
development. The identification of these protein-protein interactions may provide important clues as to 
how these associations may lead to the development of cancers and, therefore, how best to treat them. 
In this study, we sought to identify if GRK6 can interact with various proteins associated with negative or 
positive prognosis of pancreatic cancer and, if there are connections, what this may mean in terms of their 
effect on biological and molecular activities. 
Methods  
 In this study, the phosphorylation site predictors Phosphonet and GPS (versions 3.0 and 5.0) were 
utilized to determine if GRK6 is predicted to phosphorylate the top 20 proteins found to be most 
associated with negative or positive prognosis according to proteinatlas.org. For the top 6 proteins 
identified to be the most likely proteins phosphorylated by GRK6 by these sites, their biological and 
molecular functions from their gene ontology terminologies were collected and word clouds generated 
to determine common trends associated with these top 6 proteins.  
Results  
In this study, we found that several proteins from the negative or positive prognosis lists were 
predicted to more likely be GRK6 substrates compared to others, suggesting a potential specificity for 
GRK6- protein interactions among proteins most likely to be linked to cancer prognosis. Biologically, the 
top 6 proteins associated with negative prognosis and GRK6 were more associated with cell signaling 
events whereas, for positive prognosis and GRK6, more were associated with DNA transcription. 
Molecularly, the top 6 proteins associated with GRK6 and negative prognosis were more associated with 
proteins whereas, for positive prognosis and GRK6, more were associated with DNA. 
Conclusion  
This study identified potential GRK6 substrates among the list of proteins most likely associated 
with either negative or positive prognosis of pancreatic cancer. This study showed that the proteins 
associated with negative prognosis and GRK6 the best were affiliated more with cell signaling whereas 
those best associated with positive prognosis and GRK6 were linked to DNA transcription. Overall, these 
results show that GRK6, if involved in the development of pancreatic cancer, could play different roles 
depending on if the pancreatic cancer has a positive or a negative prognosis. This may suggest that GRK6 
could potentially be a key biological marker to determine the appropriate pancreatic cancer therapy.  
